胰岛素抵抗削弱磷酸戊糖通路并损害肥胖心衰患者左室辅助装置介导的心肌恢复
本研究招募接受左室辅助装置(LVAD)支持的心衰患者,发现高体重指数(≥28.0)和胰岛素抵抗者心肌恢复较差。通过小鼠心脏卸载模型及多组学分析,证实机械卸载激活心肌胰岛素信号,促进葡萄糖摄取并分流至磷酸戊糖通路,减轻氧化应激发挥心脏保护作用;但肥胖相关胰岛素抵抗削弱该通路,胰岛素增敏剂可恢复保护效应。
要点
- 机械卸载激活心肌胰岛素信号,增加葡萄糖摄取并增强磷酸戊糖通路,减轻氧化应激,促进心衰心肌恢复。
- 肥胖(BMI≥28.0)伴胰岛素抵抗患者LVAD后心肌恢复较差,与磷酸戊糖通路受限有关。
- 胰岛素增敏剂可改善肥胖心衰患者LVAD介导的心肌恢复,为潜在治疗策略。
核心结论
- 机械卸载通过激活胰岛素信号、增强磷酸戊糖通路并减少氧化应激促进心衰心肌恢复,但肥胖诱导的胰岛素抵抗削弱这一保护作用。
- 给予胰岛素增敏剂可改善肥胖心衰患者LVAD介导的心肌恢复。
研究设计与样本
- 研究对象为接受LVAD支持的心衰患者,并采用小鼠异位心脏移植模型模拟LVAD卸载。
- 运用单核RNA测序、稳定同位素示踪代谢组学、体外周期性牵拉实验等方法。
主要发现
- 体重指数≥28.0且胰岛素抵抗较重的心衰患者LVAD后心肌恢复较差。
- 机械卸载激活心肌胰岛素信号、增加葡萄糖摄取,并使其优先进入磷酸戊糖通路。
- 卸载减少心肌细胞Hippo通路激活,促进胰岛素信号及磷酸戊糖通路通量。
- 小鼠卸载心脏中磷酸戊糖通路通量增加可降低氧化应激并发挥心脏保护作用。
- 肥胖小鼠中胰岛素抵抗削弱上述保护效应,而胰岛素增敏剂可缓解胰岛素抵抗并恢复卸载介导的心脏保护。
关键数值与推荐
- BMI≥28.0为高体重指数分组阈值,且该组患者心肌恢复较差。
临床怎么用
- 临床评估肥胖心衰患者LVAD术后心肌恢复时,应关注胰岛素抵抗状态。
- 考虑使用胰岛素增敏剂以改善肥胖心衰患者的LVAD介导心肌恢复。
局限性
- 研究基于单中心或特定人群,且动物模型与人体存在差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: End-stage heart failure (HF) remains a major global health challenge, and left ventricular assist devices (LVADs) represent an important therapeutic option. LVAD-mediated mechanical unloading improves cardiac function and promotes myocardial recovery in many patients with HF; however, this recovery response is suboptimal in obese patients. The mechanisms by which LVAD-mediated unloading induces myocardial recovery, and how obesity alters these processes to blunt myocardial recovery, remain poorly understood. METHODS: Patients with HF receiving LVAD support were recruited to investigate the correlation between patients' body mass index and the myocardial recovery response following LVAD implantation. In parallel, a mouse model of heterotopic cervical heart transplantation was used to simulate LVAD-mediated cardiac unloading. Single-nucleus RNA sequencing and stable-isotope tracing metabolomics were performed to explore the changes of signaling pathways and metabolic processes in unloaded hearts. In vitro cyclic stretch assays were used to evaluate how reduced mechanical load regulates cardiomyocyte metabolic pathways. Unloaded hearts from HF mice were used to determine whether the identified metabolic processes contribute to unloading-induced myocardial recovery. Furthermore, the unloaded hearts from obese HF mice were used to evaluate whether these metabolic adaptations are attenuated by obesity. RESULTS: HF patients with a higher body mass index (≥28.0) and greater insulin resistance tended to have poorer LVAD-mediated myocardial recovery. Single-nucleus RNA sequencing showed that mechanical unloading activated myocardial insulin signaling and increased glucose uptake. Stable-isotope tracing metabolomics further revealed that glucose taken up by unloaded hearts was preferentially shunted into the pentose phosphate pathway. Mechanistically, reduced mechanical stress attenuated Hippo pathway activation in cardiomyocytes, facilitating insulin signaling and enhancing pentose phosphate pathway flux. In unloaded hearts from HF mice, increased pentose phosphate pathway flux could reduce oxidative stress and exert cardioprotective effects. However, these benefits were blunted by insulin resistance in obese mice, whereas treatment with insulin sensitizers alleviated insulin resistance and restored unloading-mediated cardioprotection. CONCLUSIONS: In failing hearts, mechanical unloading leads to activation of insulin signaling, resulting in increased glucose uptake and enhanced pentose phosphate pathway flux to protect cardiomyocytes against oxidative stress. However, this cardioprotective effect is attenuated by obesity-induced insulin resistance. Administration of insulin sensitizers has the potential to improve LVAD-mediated myocardial recovery in obese patients with HF.
引用
- Pan, Liu, Jiang, et al. Insulin Resistance Compromises the Pentose Phosphate Pathway and Impairs Left Ventricular Assist Device-Mediated Myocardial Recovery in Obese Patients With Heart Failure. Circulation. 2026. PMID: 41645902. doi:10.1161/CIRCULATIONAHA.124.072850
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。